FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TASURGRATINIB
异名/同义词1-(2-HYDROXYETHYL)-7-(2-METHOXYETHOXY)-N-METHYL-3- OXO-7H-6-OXA-4-AZA-7(5)-INDOLA-5(2,4)-PYRIDINA-1(4)-PIPERIDINA-2(1,4)-BENZENAHEPTAPHANE-7-CARBOXAMIDE
1H-INDOLE-1-CARBOXAMIDE, 5-((2-((4-(1-(2-HYDROXYETHYL)-4-PIPERIDINYL)BENZOYL)AMINO)-4-PYRIDINYL)OXY)-6-(2-METHOXYETHOXY)-N-METHYL-
5-((2-(((4-(1-(2-HYDROXYETHYL)PIPERIDIN-4-YL)PHENYL)CARBONYL)AMINO)PYRIDIN-4-YL)OXY)-6-(2-METHOXYETHOXY)-N-METHYL-1H-INDOLE-1-CARBOXAMIDE
E 7090 [WHO-DD]
E7090
E-7090
FGF/FGFR PATHWAY INHIBITOR E7090
TASURGRATINIB
TASURGRATINIB [INN]
CAS登记号1622204-21-0
物质唯一标识(Unique Ingredient Identifier)TN7CUD1NGA
分子式C32H37N5O6
国际化合物标识(International Chemical Identifier,InChI)IBHOLSBDZMIPPT-UHFFFAOYSA-N
SMILESCNC(n1ccc2cc(c(cc21)OCCOC)Oc3ccnc(NC(c4ccc(C5CCN(CCO)CC5)cc4)=O)c3)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System